Lifecare ASA: Mandatory notification of trade

26 Sep 2025 18:40 CEST

Please refer to the attached PDMR-form for details.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring ("CGM") systems to market.
Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor
technology is suitable for identifying and monitoring the occurrence of a wide
range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication at
2025-09-26 18:40 CEST.

More information:
Access the news on Oslo Bors NewsWeb site

656274_PDMR Attachment.pdf
656274_Lifecare ASA- Mandatory notification of trade.pdf